Shufen Xu

Dr. Shufen Xu

Nanjing Medical University, Nanjing, Jiangsu, China
+1

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YXYue Xu
Yue Xu
HLHua Li
Hua Li
SXShufen Xu
Shufen Xu
XLXian Liu
Xian Liu
JLJingjing Lin
Jingjing Lin
ZYZhenwei Yuan
Zhenwei Yuan

27 September 2022 in Cells
Verified
Journal Article
Open access
PDF file
YBYibo Bian
Yibo Bian
YWYang Wang
Yang Wang
SXShufen Xu
Shufen Xu
ZGZhishuang Gao
Zhishuang Gao
CLChao Li
Chao Li
KWKeming Wang
Keming Wang
Background: Long non-coding RNAs modulate tumor occurrence through different molecular mechanisms. It had been reported that HNF1A-AS1 (HNF1A Antisense RNA 1) was differently expressed in multiple tumors. The role of HNF1A-AS1 in colorectal cancer was less analyzed, and the mechanism of regulating the cell cycle has not been completely elucidated. Methods: Differentially expressed lncRNAs were screened out from the TCGA database. HNF1A-AS1 was examined in CRC clinical samples and cell lines by RT-qPCR. CCK8 assay, colony formation assay, flow cytometry, transwell assays, tube forming assay and vivo experiments were performed to study the function of HNF1A-AS1 in CRC tumor progression. Bioinformatic analysis, luciferase report assay, RNA pull-down and RIP assays were carried out to explore proteins binding HNF1A-AS1 and the potential downstream targets. Results: Our results showed that HNF1A-AS1 was upregulated in CRC and associated with unfavorable prognosis. HNF1A-AS1 promoted proliferation, migration and angiogenesis, accelerated cell cycle and reduced cell apoptosis in CRC. Bioinformatics prediction and further experiments proved that HNF1A-AS1 could promote CCND1 expression by suppressing PDCD4 or competitively sponging miR-93-5p. Meanwhile, METTL3 mediated HNF1A-AS1 m6A modification and affected its RNA stability. HNF1A-AS1/IGF2BP2/CCND1 may act as a complex to regulate the stability of CCND1. Conclusion: In summary, our result reveals the novel mechanism in which m6A-mediated HNF1A-AS1/IGF2BP2/CCND1 axis promotes CRC cell cycle progression, along with competitively sponging miR-93-5p to upregulate CCND1, demonstrating its significant role in cell cycle regulation and suggesting that HNF1A-AS1 may act as a potential prognostic marker of colorectal cancer in the future.

20 April 2022 in ACS Sensors
Verified
Journal Article
Closed access
YXYue Xu
Yue Xu
HCHaiyan Chen
Haiyan Chen
SXShufen Xu
Shufen Xu
JLJi Liu
Ji Liu
YCYang Chen
Yang Chen
BLBowen Li
Bowen Li

25 June 2021 in Cellular Oncology
Verified
Journal Article
Closed access
PDF file
YWYuting Wang
Yuting Wang
WZWen Zhang
Wen Zhang
LCLin Chen
Lin Chen
WCWei Chen
Wei Chen
SXShufen Xu
Shufen Xu
LMLin Miao
Lin Miao